Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2013
06/20/2013US20130158261 Protease inhibitors
06/20/2013US20130158076 Methylene Urea Derivatives
06/20/2013US20130158057 Aminopyrimidine derivatives as lrrk2 modulators
06/20/2013US20130158037 Compounds and methods for treating tuberculosis infection
06/20/2013US20130158034 Trpm8 antagonists and their use in treatments
06/20/2013US20130158032 Aminopyrimidine derivatives as lrrk2 modulators
06/20/2013US20130158029 Sigma receptor inhibitors
06/20/2013US20130158021 Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
06/20/2013US20130158020 Indazole derivatives useful as erk inhibitors
06/20/2013US20130158019 Pyrimidine compounds that inhibit anaplastic lymphoma kinase
06/20/2013US20130158011 Novel compounds
06/20/2013US20130158009 Piperidinyl-substituted lactams as gpr119 modulators
06/20/2013US20130158006 Aminopyrimidine derivatives as lrrk2 modulators
06/20/2013US20130158005 Pyrimidine derivatives as fak inhibitors
06/20/2013US20130158004 Azetidine Derivatives
06/20/2013US20130158003 Heteroaryl compounds and methods of use thereof
06/20/2013US20130158001 Substituted 3-phenyl-1,2,4-oxadiazole compounds
06/20/2013US20130157997 Benzimidazole analogues for the treatment or prevention of flavivirus infections
06/20/2013US20130157996 Trpm8 antagonists and their use in treatments
06/20/2013CA2858025A1 Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor
06/20/2013CA2857197A1 Novel glp-1 receptor modulators
06/19/2013EP2604606A1 Inhibitor of casein kinase 1 and casein kinase 1
06/19/2013EP2604602A1 Heteroaryl-pyrazole derivative
06/19/2013EP2604597A1 Heterocyclic compound and use thereof
06/19/2013EP2604595A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
06/19/2013EP2603506A1 Process for making linezolid
06/19/2013EP2603505A1 Process for making linezolid
06/19/2013EP2603504A1 Hepatitis c virus inhibitors
06/19/2013EP2603502A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors
06/19/2013EP2603500A1 Inhibitors of bruton's tyrosine kinase
06/19/2013EP2603496A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
06/19/2013EP2603216A1 Heteroaryls and uses thereof
06/19/2013EP2603079A1 Positive allosteric modulators of mglur2
06/19/2013CN103168037A Synthesis and use of kinase inhibitors
06/19/2013CN103159751A A preparation method for the derivates of phenylpyruvic acid amide ketals
06/19/2013CN103159742A 5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound serving as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor
06/19/2013CN103159693A Chiral aryl-substituted phenyl-1,3-oxazoline compound and synthesis method thereof
06/19/2013CN102276585B Preparation method for and medicinal usage of 4-substituted-phenyl-aryl-carboxylate derivatives
06/19/2013CN101910159B Process for production of heterocycle-substituted pyridine derivative
06/19/2013CN101880276B Substituted diazepan compounds as orexin receptor antagonists
06/19/2013CN101809099B Organic fluorescent sulfonyl ureido benzoxazinone pigments
06/19/2013CN101754966B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
06/19/2013CN101678214B 芳基醚哒嗪酮衍生物 Aryl ether pyridazinones
06/18/2013US8466282 Heterocyclic compound and use thereof
06/18/2013US8466165 4-phenylamino-quinazolin-6-yl-amides
06/18/2013US8466149 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-I
06/18/2013US8466148 1,2-disubstituted heterocyclic compounds
06/18/2013US8466146 Cyclothiocarbamate derivatives as progesterone receptor modulators
06/18/2013US8466145 Dipeptidyl peptidase IV inhibitors
06/18/2013CA2567506C Cyclic amide derivatives, and their production and use as antithrombotic agents
06/13/2013WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors
06/13/2013WO2013085957A1 Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors
06/13/2013WO2013085954A1 Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors
06/13/2013WO2013085018A1 Phenylpyrrole derivative
06/13/2013WO2013084013A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists
06/13/2013WO2013083991A1 Novel compounds and their use in therapy
06/13/2013WO2013083859A2 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
06/13/2013WO2013083774A1 Herbicidal compounds
06/13/2013WO2013083591A1 Substituted pyrazoles as mglu5 receptor modulators
06/13/2013WO2013083557A1 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
06/13/2013WO2013083556A1 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
06/13/2013WO2013048169A3 Method for preparing taxane derivatives
06/13/2013WO2013043232A3 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h) -ones for the treatment of nervous system disorders and cancer
06/13/2013WO2012177893A3 Trpm8 antagonists and their use in treatments
06/13/2013US20130150574 Process for the manufacture of chiral catalysts and their salts
06/13/2013US20130150417 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
06/13/2013US20130150411 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/13/2013US20130150377 Tetrahydropyridinyl and Dihydropyrrolyl Compounds and the Use Thereof
06/13/2013US20130150369 Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis
06/13/2013US20130150365 Insecticidal Triazines and Pyrimidines
06/13/2013US20130150360 Inhibitors of bruton's tyrosine kinase
06/13/2013US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers
06/13/2013US20130150355 Novel compounds
06/13/2013US20130150349 2,4-pyrimidinediamine compounds and their uses
06/13/2013US20130150344 Heterocyclic compound
06/13/2013US20130150341 Novel compounds
06/13/2013US20130150325 3-(Fluorovinyl)pyrazoles and their use
06/13/2013CA2858342A1 Phenylpyrrole derivative
06/13/2013CA2857198A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists
06/13/2013CA2855351A1 Novel pyrrole derivatives
06/13/2013CA2854608A1 Herbicidal compounds
06/13/2013CA2853891A1 5-(3-aminophenyl)-5-alkyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
06/13/2013CA2852366A1 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
06/12/2013EP2602248A1 Novel pyrrole compounds
06/12/2013EP2601950A1 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists
06/12/2013EP2601190A1 Isoxazoline derivatives as antiparasitic agents
06/12/2013EP2601189A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
06/12/2013EP2600874A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase
06/12/2013EP2475657B1 5-alkinylthien-2-ylcarboxylic acids as inhibitors of flaviviridae viruses
06/12/2013EP2178869B1 Indole compounds as an inhibitor of cellular necrosis
06/12/2013CN1854135B Heteronuclear compound with dicyandiamide connection and its medicinal use
06/12/2013CN103155268A Photoelectric conversion element, pigment for photoelectric conversion element and compound
06/12/2013CN103153990A Novel pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof
06/12/2013CN103153978A Compounds and methods for the treatment or prevention of flaviviridae viral infections
06/12/2013CN103153970A Oxazole And Thiazole Compounds As Ksp Inhibitors
06/12/2013CN103153968A Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
06/12/2013CN103153963A Cyclopropane compound
06/12/2013CN103153957A N-pyridin-3-yl or N-pyrazin-2-yl carboxamides
06/12/2013CN103153951A Pyrrolidinones as MetAP-2 inhibitors
06/12/2013CN103145702A Aminopyrimidines useful as kinase inhibitors
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 647